Phospho-soda, 45 ml 2 pcs.

Phospho-soda is a salt laxative whose action is based on increasing water retention in the small intestine lumen through osmotic processes.

Liquid accumulation in the ileum leads to increased peristalsis and subsequent purification of the intestine.

Indications

Preparing for endoscopic or radiological examination of the colon, preparing for surgical intervention on the colon.

Active ingredient

Composition

1 vial (45 ml) contains:

Active ingredients:

Sodium hydrophosphate dodecahydrate240 mg (10.8 g);

Sodium dihydrophosphate dihydrate542 mg (24.4 g);

component of the composition without quantity;

Auxiliary substances:

Glycerol 99%;

Sodium saccharin;

Sodium benzoate (E211);

ginger and lemon flavoring (ginger oil, alcohol, lemon oil, partially stabilized lemon oil, citric acid, water);

purified water.

How to take, the dosage

Fleet Phospho Soda is prescribed for adults and adolescents over 15 years of age. Doses similar to those for adults are used for older patients.

The drug should be started the day before the scheduled procedure.
If the procedure is scheduled before noon, the instructions for the morning appointment must be followed. If the procedure is scheduled for the time after noon, the instructions for the afternoon appointment must be followed.

Morning appointment.
The day before the procedure.

The second dose is taken immediately after dinner. Dissolve the contents of the second bottle (45 ml) in half a glass (120 ml) of cold water. Then drink the solution and drink one glass (240 ml) of cold water. If desired, you can drink more fluids.
If necessary, you can drink “light liquids” and water until midnight.

Day appointment.
The day before the procedure.

The second dose is taken immediately after breakfast. Dissolve the contents of the second bottle (45 ml) in half a glass (120 ml) of cold water. Then drink the solution and drink one glass (240 ml) of cold water. If desired, you can drink more fluids.
“Light liquids” and water can be consumed until 8:00.

The drug usually causes stools within half an hour to 6 hours.

Special Instructions

Fleet Phospho Soda is not used for the treatment of constipation.

With caution in elderly and frail patients, patients with reduced renal function, heart disease, colostomy, and patients on a low-salt diet because of the potential for hyperphosphatemia, hypocalcemia, hypokalemia, dehydration due to hypernatriemia and acidosis.

The patient should be warned about the expected frequent liquid stools. Very rarely, single or multiple aphtho-like changes were observed on endoscopy on the mucosa of the sigmoid and rectum. These were either lymphoid follicles, or discrete formations of inflammatory nature, or epithelium changes caused by the preparation performed. These abnormalities are not clinically significant and disappear spontaneously without treatment. Rarely, prolongation of the QT interval on ECG as a result of electrolyte imbalance of the type of hypocalcemia or hypokalemia is observed.

Perhaps use with caution in persons taking calcium channel blockers, diuretics, lithium-based agents, and other drugs that can affect electrolyte levels because there is a possibility of developing hyperphosphatemia, hypocalcemia, hypokalemia, dehydration with hypernatriemia, and acidosis.

The absorption of drugs in the gastrointestinal tract may be delayed or even completely stopped while taking the drug. The effect of regularly taken drugs (e.g., oral contraceptives, antiepileptics, anti-diabetics, antibiotics) may be reduced or absent altogether.

Contraindications

Side effects

Digestive system disorders: nausea, vomiting, abdominal pain, abdominal distension, diarrhea; very rarely – during endoscopy on the mucosa of the sigmoid and rectum – single or multiple aphthous formations may be observed (clinically insignificant, spontaneously disappear without treatment).

CNS disorders: asthenia, weakness, headache, dizziness.

Metabolism disorders: in some patients from risk groups – dehydration and/or electrolyte imbalance (including hyperphosphatemia, hypocalcemia, hypokalcemia, hypernatriemia, acidosis).

Others: allergic reactions.

Pregnancy use

Phlit Phospho Soda should not be used in pregnancy because there is insufficient reliable data on the ability of the drug to have toxic effects on the fetus and/or to cause abnormal fetal development.

Because sodium phosphate is excreted with breast milk, you should stop breastfeeding immediately after the first dose of the drug and for the next 24 hours after the last dose.